Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Salvador Augustin"'
Autor:
Nuria Fernández-Hidalgo, Arnau Monforte-Pallarés, Fernando Salvador, Simeón Eremiev-Eremiev, Marta Miarons, Benito Almirante, Santiago Pérez-Hoyos, Júlia Sellarès-Nadal, Adrián Sánchez-Montalvá, Xavier Durà, Salvador Augustin, Júlia Sampol, Juan Espinosa-Pereiro, Alfredo Guillén-Del-Castillo, Abiu Sempere-González, Andrés Antón, Pau Bosch-Nicolau
Publikováno v:
Medicina Clinica
Modulation of the immune system to prevent lung injury is being widely used against the new coronavirus disease (COVID-19). The primary endpoint was mortality at 7 days after tocilizumab administration. Secondary endpoints were admission to the inten
Autor:
Harry J. de Koning, Ivica Grgurević, Patrick S. Kamath, Laurent Castera, Emmanuel Tsochatzis, Frank Lammert, Isabel Graupera, Ann T. Ma, Núria Fabrellas, Dominique Roulot, Pere Ginès, Mª Alba Diaz, Salvador Augustin, Andrea Martini, Vincent Wai-Sun Wong, Judit Pich, Rosa Maria Morillas, Philip N. Newsome, Miquel Serra-Burriel, Maja Thiele, Aleksander Krag, Phillipp Hartmann, Robert J. de Knegt, Michael P Manns, Montserrat García-Retortillo, Jörn M. Schattenberg, Indra Neil Guha, Alina M. Allen, Llorenç Caballería
Publikováno v:
Scientia
Hepatology
Ginès, P, Castera, L, Lammert, F, Graupera, I, Serra-Burriel, M, Allen, A M, Wong, V W-S, Hartmann, P, Thiele, M, Caballeria, L, de Knegt, R J, Grgurevic, I, Augustin, S, Tsochatzis, E A, Schattenberg, J M, Guha, I N, Martini, A, Morillas, R M, Garcia-Retortillo, M, de Koning, H J, Fabrellas, N, Pich, J, Ma, A T, Diaz, M A, Roulot, D, Newsome, P N, Manns, M, Kamath, P S, Krag, A & LiverScreen Consortium Investigators 2022, ' Population screening for liver fibrosis : Toward early diagnosis and intervention for chronic liver diseases ', Hepatology, vol. 75, no. 1, pp. 219-228 . https://doi.org/10.1002/hep.32163
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Hepatology
Ginès, P, Castera, L, Lammert, F, Graupera, I, Serra-Burriel, M, Allen, A M, Wong, V W-S, Hartmann, P, Thiele, M, Caballeria, L, de Knegt, R J, Grgurevic, I, Augustin, S, Tsochatzis, E A, Schattenberg, J M, Guha, I N, Martini, A, Morillas, R M, Garcia-Retortillo, M, de Koning, H J, Fabrellas, N, Pich, J, Ma, A T, Diaz, M A, Roulot, D, Newsome, P N, Manns, M, Kamath, P S, Krag, A & LiverScreen Consortium Investigators 2022, ' Population screening for liver fibrosis : Toward early diagnosis and intervention for chronic liver diseases ', Hepatology, vol. 75, no. 1, pp. 219-228 . https://doi.org/10.1002/hep.32163
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Population screening; Liver fibrosis; Early diagnosis Cribratge de població; Fibrosi hepàtica; Diagnòstic precoç Cribado de población; Fibrosis hepática; Diagnóstico precoz Cirrhosis, highly prevalent worldwide, develops after years of hepatic
Autor:
Joan Carles García-Pagán, Rosa Maria Morillas, PreDesCI Study Investigators, Joan Genescà, Agustín Albillos, Rafael Bañares, Carles Aracil, Beatriz Peñas, Edilmar Alvarado, Jaume Bosch, Jose Luis Calleja, Salvador Augustin, Juan G. Abraldes, Maria A. Poca, Anna Brujats, Ferran Torres, Càndid Villanueva
Publikováno v:
Journal of Hepatology. 75:589-599
Background & Aims The prognosis of compensated cirrhosis is good until decompensation. In decompensated cirrhosis, bacterial infections (BIs) are common and increase the risk of death. The incidence and prognostic implications of BIs in compensated c
Autor:
Maria Buti, Sergio Rodríguez-Tajes, Zoe Mariño, Xavier Forns, Salvador Augustin, Juan Ignacio Esteban, Sabela Lens, Joan Genescà, Victor Vargas, Beatriz Minguez, Mònica Pons
Publikováno v:
Hepatobiliary Surg Nutr
It is important to know which patients with hepatitis C are likely to develop liver-related complications after achieving a sustained virological response (SVR) to direct-acting antiviral (DAA) therapy. We aimed to describe the incidence of liver-rel
Autor:
Joan Genescà, Mar Gil, Anabel Fernández-Iglesias, Miren Bravo, Diana Hide, Aurora Barberá, Salvador Augustin, María Martell, Imma Raurell, María Teresa Salcedo
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports
Non-alcoholic steatohepatitis (NASH) is a common chronic liver disorder in developed countries, with the associated clinical complications driven by portal hypertension (PH). PH may precede fibrosis development, probably due to endothelial dysfunctio
Autor:
Francisco Rodríguez-Algarra, Mar Riveiro, Ernesto Casis, Salvador Augustin, Ariadna Rando-Segura, Mònica Pons, M. Buti, Yolanda Villena, Albert Blanco-Grau, Rosa Lopez-Martinez, Pablo Gabriel-Medina, Roser Ferrer-Costa, Luz-Maria Cruz, Belen Enfedaque, Francisco Rodriguez-Frias
Publikováno v:
Diagnostics
Diagnostics; Volume 11; Issue 12; Pages: 2236
Diagnostics, Vol 11, Iss 2236, p 2236 (2021)
Scientia
Diagnostics; Volume 11; Issue 12; Pages: 2236
Diagnostics, Vol 11, Iss 2236, p 2236 (2021)
Scientia
Chronic liver disease; Fibrosis 4 score Malaltia hepàtica crònica; Puntuació de fibrosi 4 Enfermedad crónica del hígado; Puntuación de fibrosis 4 Liver disease is frequently asymptomatic, challenging early identification in the primary care set
Autor:
Alexia Laroyenne, Laura Turco, Sven Francque, Lucile Moga, Johannes Chang, Jonel Trebicka, Sabela Lens, Thomas Reiberger, Wilhelmus J. Kwanten, Luis Téllez, Bogdan Procopet, Diego Burgos-Santamaría, Rafael Bañares, Georg Semmler, Giulia Tosetti, Rafael Paternostro, Filippo Schepis, Élise Vuille-Lessard, Helena Masnou, Pol Olivas, Miquel Serra-Burriel, Thomas Vanwolleghem, Pere Ginès, Càndid Villanueva, Isabel Graupera, Annalisa Cippitelli, Annalisa Berzigotti, Angela Puente, Wim Laleman, Virginia Hernández-Gea, Luis Ibañez, J.C. Garcia-Pagan, Elba Llop, Mattias Mandorfer, Edilmar Alvarado, Pierre-Emmanuel Rautou, Horia Stefanescu, Oana Farcau, Hélène Larrue, Xavier Forns, Octavi Bassegoda, Cristophe Bureau, Jose Ignacio Fortea, Salvador Augustin, Agustín Albillos, Francesca Miceli, Massimo Primignani, Alexander Zipprich
Publikováno v:
Clinical Gastroenterology and Hepatology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Bassegoda, Octavi; Olivas, Pol; Turco, Laura; Mandorfer, Mattias; Serra-Burriel, Miquel; Tellez, Luis; Kwanten, Wilhelmus; Laroyenne, Alexia; Farcau, Oana; Alvarado, Edilmar; Moga, Lucile; Vuille-Lessard, Elise; Fortea, Jose Ignacio; Ibañez, Luis; Tosetti, Giulia; Vanwolleghem, Thomas; Larrue, Hélène; Burgos-Santamaría, Diego; Stefanescu, Horia; Paternostro, Rafael; ... (2022). Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease. Clinical gastroenterology and hepatology, 20(10), 2276-2286.e6. Elsevier 10.1016/j.cgh.2021.10.023
Clinical gastroenterology and hepatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Bassegoda, Octavi; Olivas, Pol; Turco, Laura; Mandorfer, Mattias; Serra-Burriel, Miquel; Tellez, Luis; Kwanten, Wilhelmus; Laroyenne, Alexia; Farcau, Oana; Alvarado, Edilmar; Moga, Lucile; Vuille-Lessard, Elise; Fortea, Jose Ignacio; Ibañez, Luis; Tosetti, Giulia; Vanwolleghem, Thomas; Larrue, Hélène; Burgos-Santamaría, Diego; Stefanescu, Horia; Paternostro, Rafael; ... (2022). Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease. Clinical gastroenterology and hepatology, 20(10), 2276-2286.e6. Elsevier 10.1016/j.cgh.2021.10.023
Clinical gastroenterology and hepatology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
BACKGROUND & AIMS: Portal hypertension is the strongest predictor of hepatic decompensation and death in patients with cirrhosis. However, its discriminatory accuracy in patients with nonalcoholic fatty liver disease (NAFLD) has been challenged becau
Publikováno v:
Transplantation. 105(12)
Malnutrition is a frequent complication in patients with cirrhosis and liver transplant (LT) candidates. It is highly related to sarcopenia, and their implications in morbidity and mortality go beyond the waiting list period throughout the post-LT. H
Autor:
José A. Carrión, Rosa Maria Morillas, Pere Ginès, Isabel Serra, Antonio Siso-Almirall, Salvador Augustin, Maria Rosa Hernández, Teresa Broquetas, Llorenç Caballería, Isabel Graupera, Lluís Vila, Mercè Vergara, Silvia Virolés, José Manuel Fernández-Real, Rosa Solans, Alberto Goday
Publikováno v:
Medicina Clínica (English Edition). 153:169-177
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, with a prevalence of 20-30% in the general population and 60-80% in at-risk populations. In a not negligible percentage of patients, NAFLD progresses from ste
Autor:
Edilmar Alvarado, Joan Genescà, Beatriz Peñas, Agustín Albillos, Carles Aracil, Rafael Bañares, José Luis Calleja, Maria A. Poca, Juan G. Abraldes, Rosa M Morillas, Càndid Villanueva, Ferran Torres, Jaume Bosch, Joan C Garcia-Pagan, Salvador Augustin
Publikováno v:
The Lancet. 393:1597-1608
Summary Background Clinical decompensation of cirrhosis is associated with poor prognosis. Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure gradient (HVPG) ≥10 mm Hg, is the strongest predictor of decompensati